Cardiac POC Testing Devices Market – Global Research and Analysis 2024
According to a report published by the Heart Foundation—an Australia-based organization focused on increasing awareness about heart disease—heart disease (including Stroke and other Cardiovascular Diseases) is the main cause of death in the U.S., leading to the death of nearly 787,000 people in 2011. The same report stated that around 720,000 individuals in the U.S. suffer from heart attacks each year. Of these attacks, 515,000 are first heart attacks and the rest 205,000 happened in patients who have already experienced a heart attack. North America is characterized by a robust healthcare infrastructure and is well equipped with technologically advanced instruments such as new age cardiac POC testing devices for monitoring the condition in patients suffering from cardiovascular diseases. These are some of the reasons for dominance of the North America in the global cardiac POC testing devices industry.
Request to view table of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/192
However, Asia Pacific is likely to gain significant momentum in the near future. According to a report published by National Centre for Biotechnology Information in 2013, cardiovascular disease (CVD) is the major cause of death in the globe and around half of these CVD cases were expected to be reported in Asia. When compared with the Western world, most Asian countries, excluding Japan, Singapore, Thailand, and South Korea, account for high mortality (age-adjusted) from CVD, thereby augmenting growth of the market.
Some of the major companies operating in the cardiac POC testing devices market in the current scenario are Abbott Laboratories, Alere Inc., BG Medicine Inc., Roche Diagnostics, Beckman Coulter, Inc., Medtronic Inc., and Boston Scientific Corp.
POC or Point-of-care testing, also known as bedside testing is a diagnostic testing at or close to the point or position of care at the same place and time of patient care. Diagnostic tests have been restricted to the diagnostic centre or medical laboratory, thereby sending off blood samples away from patient care site entailed a waiting period ranging from a few days to a few weeks for the results to arrive. This necessitated continuous care of the patient by the same treatment, devoid of the crucial information and led to the deployment of point of care testing. This in turn led to growth of the cardiac POC testing devices market. POC tests are simple diagnostic tests that may be carried out at the bedside.
Cardiac POC testing is a diagnostic test related to the heart that is carried out close to the point of care of the patient. Principally, they are simple blood tests that include coagulation testing and cholesterol testing, among others. Coagulation testing helps doctors assess risk of extreme bleeding or developing thrombosis inside blood vessels in the body, including the heart. Cardiac point-of-care tests include brain natriuretic peptide analysis and Troponin, which are mainly employed to identify cardiovascular ailments such as coronary syndromes, heart failure, and myocardial infarction. Cardiac POC testing device help to detect enzymes that are released at some point in heart failure and in vital cardiac circumstances such as synthesizing troponin, kinase, brain natriuretic peptides and lactate dehydrogenase isoenzymes. Moreover, these tests help doctors detect and distinguish between angina and myocardial infarction, which are two of the major causes of heartache and death related to the same. Cardiac POC significantly decreases the time taken to get the reports. In most cases, the reports are supplied within an hour post submission of the test sample. Thus, cardiac POC tests help reduce turnaround time considerably, thereby allowing for instant patient response and effectual management of cardiac diseases. These functionalities will drive growth of the market in cardiac POC testing devices during the forecast period (2016–2024).
Cardiac POC Testing Devices Market Taxonomy
On the basis of product type, the market is classified into:
Automated molecular tests
Imaging systems Sequencing By Ligation (SBL)
On the basis of end users, the market is classified into:
Make an Enquiry @ https://www.coherentmarketinsights.com/insight/request-sample/192
Cardiac diseases and the conditions leading to them, including hypercholesterolemia, require constant monitoring of the patient and accordingly adjusting the dosage and the combination of drugs prescribed. High cholesterol can also be hereditary in nature. According to the FH Foundation—a global charity focused on increasing awareness regarding Familial Hypercholesterolemia—1 in 200-500 people suffered from familial hypercholesterolemia worldwide in 2015. With increasing population, the number is likely to rise in the future, thereby leading to an increase in demand for testing cholesterol levels in individuals. This in turn would propel overall growth of the cardiac POC testing devices market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel : +1-206-701-6702
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac POC Testing Devices Market – Global Research and Analysis 2024 here
News-ID: 497961 • Views: 252
More Releases from Cardiac POC Testing Devices Market
Cardiac POC Testing Devices Market – Global Industry Insights, Trends and Anal …
Growing prevalence of cardiac diseases, especially in Asia Pacific to drive growth of cardiac POC testing devices market According to a report published by the Heart Foundation—an Australia-based organization focused on increasing awareness about heart disease—heart disease (including Stroke and other Cardiovascular Diseases) is the main cause of death in the U.S., leading to the death of nearly 787,000 people in 2011. The same report stated that around 720,000 individuals in
Cardiac POC Testing Devices Market: Overview & Sector Analysis (2016 - 2024)
POC or Point-of-care testing, also known as bedside testing is a diagnostic testing at or close to the point or position of care at the same place and time of patient care. Diagnostic tests have been restricted to the diagnostic centre or medical laboratory, thereby sending off blood samples away from patient care site entailed a waiting period ranging from a few days to a few weeks for the results
More Releases for Asia
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
MES: Expansion in Asia
Berlin, November 24, 2014: Model Engineering Solutions (MES), the Berlin-based specialist for model-based software development, has significantly expanded its business in Asia. In recent years, MES has built up a network of local partners in Japan, Korea, China, and India in order to benefit from the growing market and increasing interest in model-based development and ISO 26262 in Asia. Asia: Driving force in the automotive industry The automotive industry continues
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
UDT Asia 2011
Clarion Events hosts the Undersea Defence Technology (UDT) Asia 2011 conference and exhibition to bring senior naval and industry personnel together to cover underwater developments in the region Singapore, May 30 – Clarion Events is hosting UDT Asia on 30 November – 1 December 2011. The event brings together the undersea defence community in Asia, featuring top regional naval speakers, who will be addressing the latest underwater requirements for Asian navies. According